CPEX Pharmaceuticals Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction

EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today advised stockholders to vote now FOR the all-cash, premium merger agreement with FCB I Holdings Inc. (“FCB”). Stockholders will receive $27.25 per share if the merger agreement is approved. The special meeting of stockholders to approve the transaction is being held on March 24, 2011. Stockholders should not delay in voting FOR the transaction.